Exact Sciences' Cologuard Plus received FDA approval and expanded access for CRC screening in partnership with Humana and Mayo Clinic.
2 reports, 2 independent
Updated Aug 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Exact Sciences' Cologuard Plus received FDA approval and expanded access for CRC screening in partnership with Humana and Mayo Clinic.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Exact Sciences
American company in Madison, United States
Nothing else this week.
- FDA
Related events
- Zenith collaborates with Harvard researchers on clinical studies, receiving FDA clearance for the trial.
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.
- A company involving Oxford seeks FDA clearance for a new diagnostic test.
- FDA is willing to review updated submissions, while biotech hubs leverage AI to ease clinical development bottlenecks.
Coverage
Newest first; wire copies grouped- Medical Device NetworkExact Sciences expands partnership with Humana to improve colorectal cancer screening Exact Sciences has expanded its collaboration with private insurer Humana to make the Cologuard Plus test availab
- Business WireExact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus™ Test Cologuard Plus™ Available In-Network August 2025 MADISON, Wis., July 31, 2025--(BUSINESS WIRE)--Exac